Adverum Biotechnologies, Inc. announced that Richard Beckman, M.D., has joined Adverum as the company's chief medical officer (CMO). Dr. Beckman will serve as a member of Adverum's executive committee and will report to Laurent Fischer, M.D., president and chief executive officer. Most recently, Dr. Beckman served as the CMO at ReNeuron, Inc. Most recently, Dr. Beckman served as the CMO at ReNeuron, Inc., where he oversaw clinical development for pipeline candidates including its human retinal progenitor cell therapy program in retinitis pigmentosa.

Prior to ReNeuron, Dr. Beckman served as CMO at several companies including Clearside Biomedical, Inc., Unilife, Inc., Ophthotech, and Neurotech Pharmaceuticals, Inc. and at the latter two led clinical development programs in wet age-related macular degeneration.